PTEN and Familial prostate cancer: Furthermore, treatment of mice bearing the PTEN-negative prostate cancer xenografts with CCI-779, an ester of rapamycin combined with doxorubicin, inhibited the growth of the doxorubicin-resistant tumors confirming the observations in vitro [371].